The treatment for nursing HIV is that CD4+ T-Cells are modified with ZFNs, so killing the CD4+ T-Cells prevents HIV. The experimental group is up to 20 subjects with heterozygote CCRS delta-32 mutation who will receive a single intravenous infusion. The independent variable in this study is the modification of the CDF+ T-Cells with ZFN. The dependent variable is the prevention or no prevention of HIV. No controls were used in this study. The outcome is that ZFN modifying CD4+ T-Cells is safe for humans and the adjustment of the T-Cells help prevent
The treatment for nursing HIV is that CD4+ T-Cells are modified with ZFNs, so killing the CD4+ T-Cells prevents HIV. The experimental group is up to 20 subjects with heterozygote CCRS delta-32 mutation who will receive a single intravenous infusion. The independent variable in this study is the modification of the CDF+ T-Cells with ZFN. The dependent variable is the prevention or no prevention of HIV. No controls were used in this study. The outcome is that ZFN modifying CD4+ T-Cells is safe for humans and the adjustment of the T-Cells help prevent